Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The alpha platelet-derived growth factor receptor (PDGFRA), also known as CD140a, is a cell surface receptor tyrosine kinase that binds PDGF isoforms, activating signaling pathways regulating cell growth, differentiation, and development. It plays critical roles in embryonic development and tissue maintenance. Mutations or aberrant activity are linked to several neoplasms, including GISTs and clonal hypereosinophilia.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha platelet-derived growth factor receptor (PDGFRA).